LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Janice Reynolds <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Wed, 28 Mar 2007 10:12:16 -0600
Content-Type:
text/plain
Parts/Attachments:
text/plain (38 lines)
[from the business pages in New Zealand.the next thing in infant formula -
ear infection prevention!]

 

http://www.nzherald.co.nz/topic/story.cfm?c_id=206
<http://www.nzherald.co.nz/topic/story.cfm?c_id=206&objectid=10431344>
&objectid=10431344

Dunedin-based biotechnology firm BLIS Technologies has announced a deal with
food giant Nestle to develop natural antibiotics to beat middle-ear
infections for use in infant formula.

NZX-listed BLIS Technologies will work with Nestle to research and develop
probiotics - naturally occurring bacteria with "built in" defences against
disease causing bacteria - to protect against upper respiratory tract
infections common in infants.

Under the agreement Nestle will fund BLIS research for the development of
probiotics suitable to use in infant formula up to the clinical trial phase.
Nestle will then take responsibility for clinical studies.

(see link for full item)

Janice Reynolds

 


             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
Mail all commands to [log in to unmask]
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or [log in to unmask])
To unsubscribe: unsubscribe lactnet or ([log in to unmask])
To reach list owners: [log in to unmask]

ATOM RSS1 RSS2